-
Loading metrics
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
-
Sauman Singh-Phulgenda ,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
* E-mail: sauman.singh@iddo.org (SSP); drkrishnapandey@yahoo.com (KP)
¶‡ These authors are joint first authors on this work.
Affiliations Infectious Diseases Data Observatory (IDDO), Oxford, United Kingdom, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
⨯ - Rishikesh Kumar ,
- Prabin Dahal,
- Abdalla Munir,
- Sumayyah Rashan,
- Rutuja Chhajed,
- Caitlin Naylor,
- Brittany J. Maguire,
- Niyamat Ali Siddiqui,
- Eli Harriss,
- Manju Rahi,
- Fabiana Alves,
- Shyam Sundar,
- Kasia Stepniewska,
- Ahmed Musa,
- Philippe J. Guerin,
- [ ... ],
- Krishna Pandey
- [ view all ]
- [ view less ]
https://orcid.org/0000-0003-2892-3053
Post-kala-azar dermal leishmaniasis (PKDL) drug efficacy study landscape: A systematic scoping review of clinical trials and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
- Sauman Singh-Phulgenda,
- Rishikesh Kumar,
- Prabin Dahal,
- Abdalla Munir,
- Sumayyah Rashan,
- Rutuja Chhajed,
- Caitlin Naylor,
- Brittany J. Maguire,
- Niyamat Ali Siddiqui,
- Eli Harriss
x
-
- Published: April 16, 2024
- https://doi.org/10.1371/journal.pntd.0011635